- Home
- STFS vs BEAT Comparison
STFS vs BEAT Comparison
Compare STFS & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STFS
- BEAT
- Stock Information
- Founded
- STFS 2015
- BEAT 2015
- Country
- STFS China
- BEAT United States
- Employees
- STFS N/A
- BEAT 20
- Industry
- STFS
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- STFS
- BEAT Technology
- Exchange
- STFS NYSE
- BEAT Nasdaq
- Market Cap
- STFS 71.7M
- BEAT 74.1M
- IPO Year
- STFS 2024
- BEAT 2021
- Fundamental
- Price
- STFS $6.52
- BEAT $2.66
- Analyst Decision
- STFS
- BEAT Buy
- Analyst Count
- STFS 0
- BEAT 1
- Target Price
- STFS N/A
- BEAT $8.00
- AVG Volume (30 Days)
- STFS 1.7M
- BEAT 282.2K
- Earning Date
- STFS 12-24-2024
- BEAT 11-07-2024
- Dividend Yield
- STFS N/A
- BEAT N/A
- EPS Growth
- STFS 43.39
- BEAT N/A
- EPS
- STFS 0.15
- BEAT N/A
- Revenue
- STFS $14,972,726.00
- BEAT N/A
- Revenue This Year
- STFS N/A
- BEAT N/A
- Revenue Next Year
- STFS N/A
- BEAT N/A
- P/E Ratio
- STFS $37.15
- BEAT N/A
- Revenue Growth
- STFS 57.60
- BEAT N/A
- 52 Week Low
- STFS $2.82
- BEAT $1.06
- 52 Week High
- STFS $6.58
- BEAT $3.48
- Technical
- Relative Strength Index (RSI)
- STFS N/A
- BEAT 47.14
- Support Level
- STFS N/A
- BEAT $2.28
- Resistance Level
- STFS N/A
- BEAT $3.48
- Average True Range (ATR)
- STFS 0.00
- BEAT 0.29
- MACD
- STFS 0.00
- BEAT -0.05
- Stochastic Oscillator
- STFS 0.00
- BEAT 37.83
About STFS STAR FASHION CULTURE HOLDINGS LIMITED
Star Fashion Culture Holdings Ltd is a content marketing solutions services provider. The company offer services focusing on marketing campaign planning and execution, offline advertising services; and online precision marketing services. The services also include marketing campaign planning and execution, events including marathons, sports events, and music festivals.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.